Who have Short-term memory loss with Carcinoid tumour - from FDA reports

Short-term memory loss is found among people with Carcinoid tumour, especially for people who are female, 60+ old, take medication Sandostatin lar and have Neuroendocrine tumor. This study is created by eHealthMe based on reports of 99 people who have Carcinoid tumour from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Feb, 10, 2019

99 people who have Carcinoid Tumour and Short-Term Memory Loss are studied.

Number of reports submitted per year:

Would you have Short-term memory loss when you have Carcinoid tumour?

Gender of people who have Carcinoid Tumour and experience Short-Term Memory Loss *:

  • female: 63.16 %
  • male: 36.84 %

Age of people who have Carcinoid Tumour and experience Short-Term Memory Loss *:

  • 0-1: 0.0 %
  • 2-9: 1.69 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.39 %
  • 40-49: 8.47 %
  • 50-59: 18.64 %
  • 60+: 67.8 %

Top co-existing conditions for these people *:

  1. Neuroendocrine Tumor: 8 people, 8.08%
  2. High Blood Pressure: 6 people, 6.06%
  3. Prostate Cancer: 3 people, 3.03%
  4. Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 3 people, 3.03%
  5. Pain: 2 people, 2.02%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 2.02%
  7. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 2 people, 2.02%
  8. Enlarged Prostate: 2 people, 2.02%
  9. Peripheral Vascular Disorder: 2 people, 2.02%
  10. Pancreatic Neuroendocrine Tumor: 2 people, 2.02%

Most common drugs for these people *:

  1. Sandostatin Lar: 46 people, 46.46%
  2. Sandostatin: 20 people, 20.20%
  3. Morphine: 6 people, 6.06%
  4. Synthroid: 6 people, 6.06%
  5. Tylenol: 6 people, 6.06%
  6. Baby Aspirin: 5 people, 5.05%
  7. Amlodipine: 5 people, 5.05%
  8. Zopiclone: 5 people, 5.05%
  9. Zofran: 5 people, 5.05%
  10. Prevacid: 4 people, 4.04%

Top symptoms for these people *:

  1. Diarrhea: 53 people, 53.54%
  2. High Blood Pressure: 53 people, 53.54%
  3. Fatigue (feeling of tiredness): 50 people, 50.51%
  4. Weight Decreased: 49 people, 49.49%
  5. Nausea (feeling of having an urge to vomit): 35 people, 35.35%
  6. Weakness: 33 people, 33.33%
  7. Nausea And Vomiting: 30 people, 30.30%
  8. Stress And Anxiety: 28 people, 28.28%
  9. Malaise (a feeling of general discomfort or uneasiness): 25 people, 25.25%
  10. Blood Pressure Systolic Increased: 25 people, 25.25%

* Approximation only. Some reports may have incomplete information.

Do you have Short-term memory loss with Carcinoid tumour?

You are not alone:

Related studies

Carcinoid Tumour

Carcinoid tumour (slow growing tumour) can be treated by Sandostatin (latest reports from 5,145 Carcinoid tumour patients)

Short-Term Memory Loss

Short-term memory loss has been reported by people with multiple sclerosis, depression, pain, high blood pressure, high blood cholesterol (latest reports from 142,874 Short-term memory loss patients).

Drugs that are associated with Short-term memory loss
Short-term memory loss (3,352 drugs)
Other conditions that could cause Short-term memory loss
Short-term memory loss (3,473 conditions)
Browse all symptoms of Carcinoid tumour
a b c d e f g h i j k l m n o p q r s t u v w x y z

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!